home / stock / cwbr / cwbr news

CWBR News and Press, CohBar Inc. From 11/06/19

Stock Information
Company Name: CohBar Inc.
Stock Symbol: CWBR
Market: OTC
Website: cohbar.com
Menu
CWBR CWBR Quote CWBR Short CWBR News CWBR Articles CWBR Message Board
Get CWBR Alerts

News, Short Squeeze, Breakout and More Instantly...
CWBR - CohBar Reports Third Quarter 2019 Financial Results and Business Update

MENLO PARK, Calif., Nov. 06, 2019 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics (MBTs) to treat age-related diseases and extend healthy lifespan, today reported its financial results for the third quarter e...
CWBR - CohBar Completes Phase 1a and Initiates Phase 1b Stage of Clinical Trial of CB4211 Under Development for NASH and Obesity

MENLO PARK, Calif., Nov. 05, 2019 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics (MBTs) to treat age-related diseases and extend healthy lifespan, today announced the completion of the Phase 1a stage of the ...

CWBR - CohBar to Announce 2019 Third Quarter Financial Results and Provide Business Update on November 6, 2019

Company to host conference call and webcast at 5:00 p.m. ET MENLO PARK, Calif., Oct. 24, 2019 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat age-related diseases and extend healthy lifespan, ann...

CWBR - CohBar Expands Board with Biotech Veteran Misha Petkevich

MENLO PARK, Calif., Oct. 23, 2019 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat age-related diseases and extend healthy lifespan, today announced the appointment of Misha Petkevich to its Board of ...
CWBR - Blue Chips Join The Earnings Parade (Stocks To Watch)

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions and other key events that could impact stocks, and our single stock focus. If you are interested in listening to Stocks T...

CWBR - CohBar to Present at the 2019 BIO Investor Forum

MENLO PARK, Calif., Oct. 15, 2019 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat age-related diseases and extend healthy lifespan, announced today that its Chief Executive Officer, Steven Engle...

CWBR - CohBar (CWBR) Presents At Cantor Healthcare Conference - Slideshow

The following slide deck was published by CohBar, Inc. in conjunction with this Read more ...

CWBR - CohBar to Present at the 2019 Cantor Global Healthcare Conference

MENLO PARK, Calif., Sept. 18, 2019 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat age-related diseases and extend healthy lifespan, announced today that its Chief Executive Officer, Steven Engl...

CWBR - CohBar, Inc. (CWBR) CEO Steven Engle on Q2 2019 - Earnings Call Transcript

CohBar, Inc. (CWBR) Q2 2019 Results Earnings Conference Call August 07, 2019, 05:00 PM ET Company Participants Glenn Garmont - LifeSci Advisors Steven Engle - CEO Ken Cundy - Chief Scientific Officer Jeff Biunno - CFO Conference Call Participants Stephen Dunn - LifeTech ...

CWBR - CohBar reports Q2 results

CohBar (NASDAQ: CWBR ): Q2 GAAP EPS of -$0.07. Press Release More news on: CohBar, Inc., Earnings news and commentary, Healthcare stocks news, ,

Previous 10 Next 10